Advertisement
Advertisement
U.S. Markets close in 2 hrs 48 mins
Advertisement
Advertisement
Advertisement
Advertisement

CASI Pharmaceuticals, Inc. (CASI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.9913+0.5113 (+14.69%)
As of 01:10PM EDT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/15/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.74
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 317.4000
52 Week Low 32.2400
50-Day Moving Average 32.8810
200-Day Moving Average 36.3408

Share Statistics

Avg Vol (3 month) 3192.53k
Avg Vol (10 day) 3763.11k
Shares Outstanding 5139.8M
Implied Shares Outstanding 6N/A
Float 88.27M
% Held by Insiders 132.69%
% Held by Institutions 117.67%
Shares Short (Jul 14, 2022) 4180.12k
Short Ratio (Jul 14, 2022) 42.59
Short % of Float (Jul 14, 2022) 41.63%
Short % of Shares Outstanding (Jul 14, 2022) 41.32%
Shares Short (prior month Jun 14, 2022) 4164.28k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:11
Last Split Date 3Jun 30, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -93.65%
Operating Margin (ttm)-96.96%

Management Effectiveness

Return on Assets (ttm)-14.62%
Return on Equity (ttm)-27.67%

Income Statement

Revenue (ttm)33.49M
Revenue Per Share (ttm)2.40
Quarterly Revenue Growth (yoy)58.00%
Gross Profit (ttm)17.61M
EBITDA -30.74M
Net Income Avi to Common (ttm)-31.37M
Diluted EPS (ttm)-0.3440
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)37.48M
Total Cash Per Share (mrq)2.76
Total Debt (mrq)1.88M
Total Debt/Equity (mrq)1.91
Current Ratio (mrq)3.80
Book Value Per Share (mrq)0.62

Cash Flow Statement

Operating Cash Flow (ttm)-23.08M
Levered Free Cash Flow (ttm)-21.76M
Advertisement
Advertisement